Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized

British Journal of Haematology

Volumn 111, Issue 2, 2000, Pages 491-497

  Croizat, H ^a   Ponchio, L ^b   Nicolini, F E ^b   Nagel, R L ^a   Eaves, C J ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Colony forming cells; Cycling; Peripheral blood; Sickle cell disease; Stem cells

Indexed keywords

STEEL FACTOR;

ARTICLE; CELL CULTURE; CELL MOTILITY; CELL SEPARATION; COLONY FORMING CELL; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STEM CELL;

CELL COUNT; CELL CYCLE; ERYTHROID PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTE COUNT; SICKLE CELL TRAIT; TIME FACTORS;

EID: 0034537832     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer
2. Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient mice
3. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice
4. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential
5. Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer
6. Circulating cytokines in sickle cell patients during steady state
7. Increased plasma levels of steel factor in sickle cell anemia and its relationship to erythropoietic stress
8. Circulating BFU-E in sickle cell anemia: Relationship to percent fetal hemoglobin and BPA-like activity
9. + cells predict a rapid platelet recovery after peripheral blood stem cell transplantion
10. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation
11. Evidence for stem cells in the peripheral blood of mice
12. Human marrow cells capable of erythropoietic differentiation in vitro: Definition of three erythroid colony responses
13. Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables
14. + peripheral blood progenitor cells
15. Enhanced detection, maintenance and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human Steel factor, interleukin-3 and granulocyte colony-stimulating factor
16. Isolation of human T and B lymphocytes by E-rosette gradient centrifugation: Characterization of the isolated subpopulations
17. Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: Comparison of cytokine mobilised blood stem cells with normal bone marrow and peripheral blood
18. Circulating erythropoietic precursors assessed in culture: Characterization in normal men and patients with hemoglobinopathies
19. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells
20. Quantitation of the quiescent fraction of long term culture-initiating cells (LTC-IC) in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro
21. Both cycling and noncycling primitive progenitors continue to be mobilized into the circulation during the leukapheresis of patients pretreated with chemotherapy and G-CSF
22. Long term culture of human myeloid cells
23. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells
24. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants
25. Effect of burst-promoting activity (BPA) and erythropoietin on hemoglobin biosynthesis in culture
26. + cells
27. The biology and clinical uses of blood stem cells
28. Characterization of primitive hematopoietic cells in normal human peripheral blood
29. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level
30. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells
31. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay